REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/06/2026
Voltar para busca
Dado oficial do USPTO
IDT BIOLOGIKA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
IDT BIOLOGIKA
ST13
US500000079287117Classe
5, 40, 42
Pedido
79287117
Registro
6375151
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
09/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 40, 42
Data de depósito
19/12/2019
Data de registro
08/06/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/06/2021
Última transação
09/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
16
Localização do titular
DE
Examinador
FIRST, VIVIAN M
Unidade examinadora
M50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
IDT Biologika GmbH
Representantes
David L. May NIXON PEABODY LLP
Classificação técnica
Classes Nice
Classe 5Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medical preparations; namelyvaccinesimmunopharmaceuticalshormones; veterinary preparationsveterinary vaccinesveterinary immunopharmaceuticalshormones; medical and veterinary preparations for treating or preventing diseases caused by Sars-CoV- 2salmonellae; medical and veterinary preparations for treating or preventing corona virus diseaserabiesdiphtheriatetanusAIDSmalariatuberculosis; medical and veterinary preparations for the treatment of immune system related diseases and disorders; biotechnological preparations for medical usevaccines; biotechnological preparations for veterinary useveterinary vaccines; biotechnological preparations for medical or veterinary usefor treating or preventing diseases caused by Sars-CoV-2salmonellae; biotechnological preparations for medical or veterinary usefor treating or preventing corona virus diseaserabiesdiphtheriatetanusAIDSmalariatuberculosis; sanitary preparations for medical purposes; dietetic foods adapted for medical purposes; dietary supplements for human beings and animals; disinfectants; preparations for destroying noxious animals; fungicides
Classe 40
Contract manufacturing of pharmaceutical and veterinary preparationsbiotechnological preparations for medical and veterinary purposessanitary preparations for medical purposesdietetic foods adapted for medical purposesdietary supplements for human beings and animalsdisinfectantspreparations for destroying noxious animals and fungicides for third parties
Classe 42
Scientific and technological servicesresearchdevelopmentengineering and testing services in the fields of pharmaceuticalsimmunopharmaceuticalsvaccinesveterinary drugsveterinary immunopharmaceuticals and veterinary vaccinespharmaceutical and veterinary product evaluationquality control for othersquality control of pharmaceuticals and veterinary drugsscientific researchproduct development for otherscleanroom monitoring; medicalpharmaceutical and veterinary research services; product research and development; natural science servicesresearchdevelopmentengineering and testing services in the fields of pharmaceuticalsimmunopharmaceuticalsvaccinesveterinary drugsveterinary immunopharmaceuticals and veterinary vaccines; research relating to biotechnology; product development in the biological and biotechnological field; testinganalysis and evaluation of the goods of others to assure compliance with industry standards and industrial research in the fields of pharmaceuticalsimmunopharmaceuticalsvaccinesveterinary drugsveterinary immunopharmaceuticals and veterinary vaccines
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
30/10/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
30/09/2021
FIMP
FINAL DISPOSITION PROCESSED
30/09/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/09/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
08/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/03/2021
PUBO
PUBLISHED FOR OPPOSITION
23/03/2021
GPNX
NOTIFICATION PROCESSED BY IB
21/03/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/03/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/03/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/03/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/02/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
16/02/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
16/02/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
16/02/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
16/02/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
16/02/2021
GNFR
FINAL REFUSAL E-MAILED
16/02/2021
CNFR
FINAL REFUSAL WRITTEN
16/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/01/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/01/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
19/01/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/01/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
19/01/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19/01/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19/01/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
19/01/2021
RFNT
REFUSAL PROCESSED BY IB
07/08/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
20/07/2020
RFRR
REFUSAL PROCESSED BY MPU
20/07/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
17/06/2020
CNRT
NON-FINAL ACTION WRITTEN
16/06/2020
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
16/06/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
16/06/2020
MAFR
APPLICATION FILING RECEIPT MAILED
16/06/2020
CNRT
NON-FINAL ACTION WRITTEN
15/06/2020
DOCK
ASSIGNED TO EXAMINER
12/06/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/06/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/06/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace IDT BIOLOGIKA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.